Stephan Kirschbaum
Corporate Officer/Principal chez DOTTIKON ES HOLDING AG
Fortune : 1 M $ au 30/04/2024
Postes actifs de Stephan Kirschbaum
Sociétés | Poste | Début | Fin |
---|---|---|---|
DOTTIKON ES HOLDING AG | Corporate Officer/Principal | 01/01/2009 | - |
Dottikon Es America, Inc. | Directeur Général | - | - |
Président | - | - | |
Dottikon Exclusive Synthesis AG
Dottikon Exclusive Synthesis AG Pharmaceuticals: MajorHealth Technology Dottikon Exclusive Synthesis AG manufactures pharmaceutical ingredients. Its products and services exclusive synthesis, project management, performance chemicals, containment, quality management, recycling and waste treatment, and dottisol. The company was founded in 1913 and is headquartered in Dottikon, Switzerland. | Corporate Officer/Principal | - | - |
Historique de carrière de Stephan Kirschbaum
Anciens postes connus de Stephan Kirschbaum
Sociétés | Poste | Début | Fin |
---|---|---|---|
UBS | Corporate Officer/Principal | 01/01/2005 | 01/01/2009 |
Mckinsey & Co., Inc. (Germany) | Corporate Officer/Principal | 01/01/1999 | 01/01/2005 |
University of California, Santa Barbara | Directeur Technique/Scientifique/R&D | 01/01/1997 | 01/01/1999 |
Formation de Stephan Kirschbaum
University of Karlsruhe | Doctorate Degree |
Statistiques
Internationale
Suisse | 5 |
Allemagne | 3 |
Etats-Unis | 2 |
Opérationnelle
Corporate Officer/Principal | 4 |
Doctorate Degree | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sectorielle
Consumer Services | 3 |
Finance | 2 |
Process Industries | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
DOTTIKON ES HOLDING AG | Process Industries |
Entreprise privées | 4 |
---|---|
UBS AG
UBS AG Investment ManagersFinance UBS AG engages in the provision of financial advisory solutions for private and institutional investors, intermediaries, and wealth management clients. The firm focuses on the areas of wealth and asset management, as well as investment banking. It offers retail investment products, global financing services, investment research, bespoke financing, traditional investments, as well as bonds and equities. The company was founded in 1862 and is headquartered in Zurich, Switzerland. | Finance |
Dottikon Es America, Inc. | |
Mckinsey & Co., Inc. (Germany) | |
Dottikon Exclusive Synthesis AG
Dottikon Exclusive Synthesis AG Pharmaceuticals: MajorHealth Technology Dottikon Exclusive Synthesis AG manufactures pharmaceutical ingredients. Its products and services exclusive synthesis, project management, performance chemicals, containment, quality management, recycling and waste treatment, and dottisol. The company was founded in 1913 and is headquartered in Dottikon, Switzerland. | Health Technology |
- Bourse
- Insiders
- Stephan Kirschbaum
- Expérience